Home » Lilly Boosts Investment in Chinese Firm
Lilly Boosts Investment in Chinese Firm
Eli Lilly & Co. increased its investment in China generic-drug maker Novast Laboratories Ltd. by $20 million and expanded their collaboration to enhance Lilly’s efforts to offer branded generic medicines in the country.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May